Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #352544 on Elite Pharmaceuticals Inc (ELTP)
WeeZuhl
03/04/21 12:26 PM
#352553 RE: WeeZuhl #352544
Combining the extended release formula and the PEG-based hard shell to form a safe and effective ADF is no slam dunk, especially for a company that failed in 2 tries to get FDA approval for a simple oxyIR bead.